Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic

MR Loffredo, L Nencioni, ML Mangoni… - Journal of Peptide …, 2024 - Wiley Online Library
The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) has highlighted how urgent and necessary the discovery of new antiviral …

[HTML][HTML] Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling …

S Xu, H Yuan, L Li, K Yang, L Zhao - Arabian Journal of Chemistry, 2024 - Elsevier
Recently, human bromodomain-containing protein 2 (BRD2) has been reported as a
potential drug target in host cells to combat SARS-CoV-2 as well as to treat COVID-19. In …

[HTML][HTML] Investigating emodin derivatives against SARS-CoV-2 found in medicinal herbs

T Usha, KN Hemavathi, AK Goyal, CS Abhinand… - Kuwait Journal of …, 2024 - Elsevier
SARS-CoV-2 continues to mutate and circulate at alarming levels around the world and is
exemplified by the emergence of the new variant JN. 1. The emergence of novel SARS-CoV …

Discovery of a novel antibiotic, Transitmycin, from Streptomyces sp unveils highly efficient activities against tuberculosis and human immunodeficiency virus

V Kumar, B Ramasamy, M Doble, R Manikkam… - medRxiv, 2024 - medrxiv.org
HIV is identified as a factor that aggravates tuberculosis disease pathogenesis and its
progression to latent TB. While, TB is declared as one of the major causes for AIDS …

[PDF][PDF] Mucormycosis: An infection caused by a black fungus

AA Alsudani - 2024 - researchgate.net
The filamentous fungus that causes Mucormycosis is a newly discovered angiogenic
infection that is found in large quantities and is a member of the Zygomycete class's …